Associate Professor, Psychiatry and Human Behavior, University of California, Irvine College of Medicine
Psychiatry
Dr. Andrius Baskys, MD
|
|
Give Review
Andrius Baskys works in the field of Psychiatry. Andrius Baskys is also a published physician. He has 36 paper published. The most recent paper is: Down-regulation of mGluR5 by antisense deoxynucleotides alters pharmacological responses to applications of ACPD in the rat hippocampus. He is registered with Medicare and accepts Medicare payments.
Publications
- Integration of Genomic Information in Development of Pharmacological Vascular Dementia Prevention and Treatment Strategies.
- Pharmacological prevention and treatment of vascular Dementia: Approaches and perspectives.
- PITX3 polymorphism is not associated with Parkinson''s Disease in a Chinese population.
- α-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death.
- Regulating genetic tests: who owns the data?
- Rab-mediated endocytosis: linking neurodegeneration, neuroprotection, and synaptic plasticity?
- Vascular Dementia: pharmacological treatment approaches and perspectives.
- Effects of galantamine on working memory and global functioning in patients With mild cognitive impairment: a double-blind placebo-controlled study.
- Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?
- Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis.
- Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies.
- Antisense oligonucleotide against GTPase Rab5b inhibits metabotropic agonist DHPG-induced neuroprotection.
- Lewy body Dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
- Recognizing and responding to atypical antipsychotic side effects.
- Changes in hippocampal gene expression after neuroprotective activation of group I metabotropic glutamate receptors.
- Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated With reduction of NMDA stimulated currents.
- Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated With the amyloid peptide Abeta(25-35).
- Glutamate-mediated neuroprotection against N-methyl-D-aspartate toxicity: a role for metabotropic glutamate receptors.
- Down-regulation of mGluR5 by antisense deoxynucleotides alters pharmacological responses to applications of ACPD in the rat hippocampus.
- Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices.
- Brain tissue hydrolysate, Cerebrolysin, acts on presynaptic adenosine receptors in the rat hippocampus.
- Brain tissue hydrolysate acts on presynaptic adenosine receptors in the rat hippocampus.
- Haloperidol and loxapine but not clozapine increase synaptic responses in the hippocampus.
- Effects of brain tissue hydrolysate on synaptic transmission in the hippocampus.
- Altered modulatory actions of serotonin on dentate granule cells of aged rats.
- Reversed ethanol effects on potassium conductances in aged hippocampal dentate granule neurons.
- The effects of serotonin on N-methyl-D-aspartate and synaptically evoked depolarizations in rat neocortical neurons.
- Modulatory actions of serotonin on ionic conductances of hippocampal dentate granule cells.
- NMDA depolarizations and long-term potentiation are reduced in the aged rat neocortex.
- NMDA and quisqualate reduce a Ca-dependent K+ current by a protein kinase-mediated mechanism.
- Long-term potentiation of synaptic responses in the rat dentate gyrus is due to increased quantal content.
- Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus.
- Trans-ACPD depresses synaptic transmission in the hippocampus.
- Metabotropic receptors and ''slow'' excitatory actions of glutamate agonists in the hippocampus.
- Rearrangement of centromeric satellite DNA in hippocampal neurons exhibiting long-term potentiation.
Schools
Vilnius V Kapsukas State University
University Of Toronto Hospitals
McMaster University Faculty of Health Sciences
Toronto Western Hospital
University of California At San Francisco
Procedures Preformed
- Medication Management
- Neuropsychological Testing
- Psychiatric Evaluation
- Psychiatric Medication Therapy
- View All
Conditions Treated
- Alzheimer's Disease
- Alzheimer's Disease With Early-Onset
- Alzheimer's Disease With Late-Onset
- Alzheimer's Disease Without Neurofibrillary Tangles
- View All
Doctors Specialties
- Geriatric Psychiatry
- Neuropsychiatry (Psychiatry)
- Psychiatry
Accepted Insurances
- Inland Empire Health Plan
- Special Needs Plan SNP
Education
-
Vilnius University Faculty of Medicine
Drug Facts
| NPI NUMBER | 1124110069 | |
| NPPES Provider LastName | BASKYS | |
| NPPES Provider FirstName | ANDRIUS | |
| NPPES Provider ZIPCode | 925061853 | |
| NPPES Provider State | CA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 1660.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124110069 |
| Last Name Of The Provider | BASKYS |
| First Name Of The Provider | ANDRIUS |
| View All |
Similar Doctors
|
Dr. Robert B. Summerour, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Xiaoying Cui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel E. Dey Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles C. Ma, MD |
|
|
Dr. Joanne T. Wyszomirski-Witkowski, MD |
|
|
Dr. Laura G. Valdovinos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lilian J. Caylan, MD |
|
|
Dr. Jonathan L. Watt, MD |
|
|
Dr. Shajitha B. Nawaz, MD
This Doctor is OpenDoctor Recommended.
|